SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001193125-24-104887
Filing Date
2024-04-22
Accepted
2024-04-22 16:18:58
Documents
1
Period of Report
2023-12-31
Effectiveness Date
2024-04-22

Document Format Files

Seq Description Document Type Size
1 ARS d830348dars.pdf ARS 788047
  Complete submission text file 0001193125-24-104887.txt   1086949
Mailing Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421
Business Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421 781-761-4904
Aldeyra Therapeutics, Inc. (Filer) CIK: 0001341235 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-36332 | Film No.: 24861416
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)